Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIofina Regulatory News (IOF)

Share Price Information for Iofina (IOF)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 19.50
Bid: 19.00
Ask: 20.00
Change: -0.50 (-2.50%)
Spread: 1.00 (5.263%)
Open: 19.50
High: 20.00
Low: 19.50
Prev. Close: 20.00
IOF Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Brine Supply Update

23 Nov 2015 07:00

RNS Number : 5415G
Iofina PLC
23 November 2015
 

 

23 November 2015

Iofina plc

("Iofina" or the "Company")

(LSE AIM: IOF)

 

Brine Supply Update

 

Iofina, specialists in the exploration and production of iodine and iodine specialty chemical derivatives, is issuing an update to the market today on the Company's iodine production in the State of Oklahoma.

 

Late last week there was a magnitude 4.7 earthquake with an epicentre approximately 5 miles due south of one of the Company's IOsorb® plants in northwest Oklahoma. There were no injuries to any Iofina employees nor damage to Company facilities. As a result, the Oklahoma Corporation Commission ("OCC") Oil and Gas Conservation Division issued an Implementation Plan to reduce salt water injection in the nearby area. In the coming weeks, the oil and gas producers who own and operate over 20 Salt Water Disposal ("SWD") injection wells in the affected area will likely be reducing injections up to 50% within a 5 mile radius and up to 25% within a 10 mile radius of the affected area at SWDs specified by the OCC. The expected result is anticipated to be a reduction of available brine to IOsorb® plants IO#3 and IO#5 in addition to a possible reduction of brine at plant IO#2. IOsorb® plants IO#4 and IO#6 are not currently affected by this injection reduction plan, but they are located in the area where SWD operational changes could possibly apply at a later date. 

As of today, the ramifications for the Company's iodine production are not certain. The Board is currently estimating that this may reduce Iofina's current production rate of crystalline iodine between 10-20% on a per annum basis from its 5 operating plants.

The Company still anticipates that it will meet H2 production targets of 260-300MT for H2 2015. The Company will be working closely together with its partners to maximize iodine production and revenue. Most of the affected SWD sites where the Company's IOsorb® plants are located are currently injecting volumes in excess of the capacity of Iofina's plants. This was by design to ensure that the Company would have adequate supplies during times of reduced production of brine by the SWD operators. The Company is investigating additional ways to increase water quality and iodine concentrations to improve the overall economics for the Company and its partners.

 

Commenting, President and CEO Tom Becker stated: "While the reduction in brine supply is likely to affect our production at 3 of our 5 IOsorb® plants, we will be working together with our partners to minimize any production losses and together will investigate means to reduce the impact of this decision by the OCC. We are pleased to be on track to meet H2 2015 crystalline iodine production guidance and we intend to provide an update to the market once the impact of this OCC decision is clearer."

 

 

 

 

For further information, please contact:

 

Dr. Tom Becker, CEO & President

Iofina plc

Tel: +44 (0)20 3006 3135

 

Christopher Raggett/Giles Rolls/Joanna Scott

finnCap Ltd

Tel: +44 (0)20 7220 0500

 

Rob Collins/Emily Morris

GMP Securities

Tel: +44(0)20 7647 2800

 

Media Contact:

Dominic Barretto/Harriet Jackson

Yellow Jersey PR Limited

Tel: +44 (0)7768 537 739

About Iofina:

Iofina specializes in the exploration and production of iodine, iodine specialty chemical derivatives and produced water. Iofina's business strategy is to identify, develop, build, own and operate iodine extraction plants currently focused in North America based on Iofina's WET® IOsorb® technology. Iofina has production operations in the United States, specifically in Montana, Kentucky and Oklahoma. It has complete vertical integration from the production of iodine in the field to the manufacture of the chemical end-products derived from iodine to the consumer and the recycling of iodine using iodinated side-streams from waste chemical processes. Iofina utilizes its portfolio of patented and patent pending technology, proprietary methods and trademarks throughout all business lines.

www.iofina.com

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCEAEFAAASSFAF
Date   Source Headline
2nd May 20247:00 amRNSFinal Results
16th Apr 20247:00 amRNSQ1 2024 Corporate Update
17th Jan 20247:00 amRNSHolding(s) in Company
15th Jan 20247:00 amRNSQ4 2023 Corporate Update
30th Nov 20237:00 amRNSIO#9 Update
20th Oct 20237:00 amRNSSigned Agreement for IO#10 and Q3 2023 Update
11th Sep 20237:00 amRNSInterim Results
25th Aug 20235:00 pmRNSHolding(s) in Company
24th Jul 20235:00 pmRNSHolding(s) in Company
20th Jul 20237:00 amRNSH1 Update and Updated Loan Facilities
14th Jun 20232:00 pmRNSResult of AGM
14th Jun 20237:00 amRNSIO#9 Iodine Plant Operating
9th May 20237:00 amRNSNotice of AGM
4th May 20237:00 amRNSInvestor Presentation
28th Apr 20234:45 pmRNSHolding(s) in Company
28th Apr 20237:00 amRNSGrant of Share Options
25th Apr 20237:00 amRNS2022 FULL YEAR RESULTS
12th Apr 20237:00 amRNSProduction Update
20th Feb 20237:00 amRNSDirector/PDMR Shareholding
6th Feb 20237:00 amRNSTrading Update
9th Jan 20237:00 amRNSMarket Update
28th Dec 20222:34 pmRNSHolding(s) in Company
14th Dec 20227:00 amRNSIofina Chemical Awarded ISO Certification
21st Nov 20227:00 amRNSChange of Adviser
28th Oct 20227:00 amRNSFinalised Terms for IO9 & Q3 Production Update
26th Sep 202211:06 amRNSSecond Price Monitoring Extn
26th Sep 202211:00 amRNSPrice Monitoring Extension
26th Sep 20227:00 amRNSInterim Results
8th Jul 20227:00 amRNSAdditional Loan Facilities and H1 Update
5th Jul 20228:54 amRNSHolding(s) in Company
22nd Jun 20222:30 pmRNSResult of AGM
20th Jun 20227:00 amRNSAppointment of Chrystal Capital Partners LLP
27th May 20227:00 amRNSNotice of AGM
26th May 20224:15 pmRNSHolding(s) in Company
26th May 20222:15 pmRNSHolding(s) in Company
24th May 20226:15 pmRNSHolding(s) in Company
20th May 20227:10 amRNSInvestor Presentation
18th May 20227:00 amRNSHolding(s) in Company
9th May 20227:00 amRNSFinal Results
5th May 20227:00 amRNSHolding(s) in Company
28th Apr 20228:38 amRNSHolding(s) in Company
19th Apr 20227:00 amRNSQ1 2022 and IO#9 Update
8th Apr 20221:07 pmRNSHolding(s) in Company
17th Mar 20227:00 amRNSDirector/PDMR Shareholding
16th Mar 20227:00 amRNSHolding(s) in Company
14th Mar 20227:00 amRNSDirector/PDMR Shareholding
11th Mar 20227:00 amRNSDirector/PDMR Shareholding
10th Mar 20227:00 amRNSDirector/PDMR Shareholding
9th Mar 20227:00 amRNSGrant of Share Options
8th Mar 20228:51 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.